ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

Free meningococcal B vaccines coming to the NT

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...

Content from other channels on our network

Nestlé develops algorithm to uncover dogs' bio age

AFGC's response to the ACCC's supermarket inquiry

Pacific Automation: Automation Components and Solutions for Australia's Food Processing Industry

What's New in Palletising

Scooping Up Success: Sajani Cups and Cones Freezes Out Stock Issues with Fishbowl

Burnet, Atomo to jointly develop active syphilis self-test

My Health Record: ADHA seeks industry input on support, maintenance

Monash, Optiscan partner to develop AI-powered endoscopes

Review proposes major health system changes

Private Health CEO Forum to tackle financial viability issues

Orica cuts particle emissions from Kooragang Island site by 95%

Custom Denning achieves first pantograph fast-charging electric bus

Air-gapped networks give a false sense of security

BHP strengthens partnership with ABB

Seamless modular I/O integration